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1. INTRODUCTION 
 
Acute pancreatitis 
Acute pancreatitis is a relatively common disease with an annual incidence of 10-20 cases per 
100,000, population in the Western world. The majority of cases are alcohol related or due to 
gallstones. Although many etiological factors are known to be involved in triggering acute 
pancreatitis, however, once the inflammatory process has been initiated, the ultimate outcome 
is relatively independent of the causative agent. Furthermore, acute pancreatitis has a wide 
spectrum of clinical manifestations, which ranges from a mild oedematous, self-limited 
disease with a fair prognosis to severe necrotizing inflammation with a fatal outcome. Despite 
numerous experimental and clinical results, the real pathomechanism of acute and chronic 
pancreatitis has not been established in detail yet. Over the last 15 years the understanding 
and management of acute pancreatitis has radically altered.  
The initial events in acute pancreatitis might occur within the acinar cells Zymogen and 
lysosomal granules are made fragile by substances such as alcohol and its metabolites. In 
gallstone pancreatitis, these granules appear colocalized within acinar cells. Products released 
by the granules lead to intracellular activation of digestive enzymes, such as trypsin, and 
acinar cell injury. The initial response is closely followed by a second stage consisting of 
immigration of leukocytes into the pancreas, due to inflammatory mechanisms. This 
important phenomenon is driven by cytokines, chemokines and other inflammatory mediators 
secreted by resident cells belonging to the innate immune system and parenchymal and 
mesenchymal cells 
1.2. Chronic pancreatitis 
In summary, CP is characterized by progressive and ultimately irreversible pancreatic injury 
that manifests clinically as maldigestion and diabetes. Alcohol abuse is the most common 
association of CP in the Western world. Important advances have been made in recent years 
with respect to our understanding of the pathogenesis of this disease, particularly related to 
the mechanisms responsible for the development of pancreatic fibrosis (a cardinal feature of 
CP) after repeated acute attacks of pancreatic necroinflammation (the necrosis-fibrosis 
concept). The pancreatic stellate cell is now established as playing a central role in 
fibrogenesis, particularly when activated either directly by toxic factors associated with 
pancreatitis (such as ethanol, its metabolites, or oxidant stress) or by cytokines released during 
pancreatic necroinflammation.  
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1.3. Cytokines 
Cytokine is a term applied to any of a rapidly growing number of small, nonstructural 
proteins or glycoproteins that serve as messengers between cells and are involved in such 
processes as cell growth and differentiation, tissue repair and remodeling, and regulation of 
the immune response. In acute and chronic inflammation, cytokines are instrumental in 
regulating the magnitude, nature, and duration of the inflammatory response. Cytokines also 
stimulate or inhibit the development of hematopietic cells. 
General properties of cytokines: they are polypeptides produced in response to microbes and 
other antigens that mediate and regulate immune and inflammatory reactions 
1.3.1 Tumor necrosis factor-alpha  
Tumor necrosis factor-alpha (TNF-α) is produced during immune and host defense 
responses as a primary mediator of immune regulation and the inflammatory response. The 
major cellular source of TNF-α is activated mononuclear phagocytes, although antigen-
stimulated T cells, Natural Killer (NK) cells, and mast cells can also secrete this protein The 
diverse role of TNF-α in mediating cellular responses are: the activation and induction of 
other cytokines such as IL-1, 6, 8, IFN-γ, transforming growth factor-beta (TGF-ß), in 
monocytes-macrophages and inhibition of differentiation and suppression of proliferation of 
these cells.  
1.3.2. Interleukine-6 
Interleukin-6 is a multifunctional cytokine, which is produced by lymphoid and non-lymphoid 
cells, such as fibroblasts, macrophages, dendritic cells, T and B lymphocytzes, endothelial 
cells, glial cells and keratinocytes. IL-6 regulates immune responses, acute-phase reactions 
and haematopoiesis. The production of IL-6 is regulated by a variety of stimuli, such as IL-1, 
TNF, IFN-β. IL-6 induces terminal differentation of B cells to antibody producing plasma 
cells.  
1.3.3. Transforming growth factor-beta (TGF-β) 
Virtually every cell in the body, including epithelial, endothelial, hematopietic, 
neuronal, and connective-tissue cells produces TGF-ß and has receptor for it. TGF-ß regulates 
the proliferation and differentiation of cells, embryonic development, wound healing, and 
angiogenesis. TGF-ß is one of the most potent regulators of the production and deposition of 
extracellular matrix. TGF-ß stimulates fibroblasts and other cells to produce extracellular-
matrix proteins and cell-adhesion proteins, including collagen, fibronectin, and integrins. 
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Increases or decreases in the production of TGF-ß have been linked to numerous disease 
states, including atherosclerosis and fibrotic disease of the kidney, lung and liver.  
1.3.3.1 SNP of TGF-ß1 gene 
It has been demonstrated that the production of TGF-ß varies from individual to 
individual and partly depends on the polymorphisms of these genes. The human gene 
encoding TGF-ß1 is located on chromosome 19q13. Several SNPs have been described in the 
TGF-ß1 gene, including a T-to-C transition at nucleotide 29 at position +869. It has been 
shown that TT homozygous genotypes are high TGF-β1 producers. The correlation between 
the TGF-ß1 gene polymorphism and the disease status has been studied in a diverse range of 
diseases such as heart diseases, acute human liver graft rejection, idiopathic pulmonary 
fibrosis, hypertension, myocardial infarction, atherosclerosis,  colon, ovarian, breast cancers; 
diabetic nephropathy, asthma, chronic obstructive pulmonary disease, multiple sclerosis and 
osteoporosis. 
1.4. Surgical treatment of CP 
Approximately 20-30% of patients with chronic pancreatitis (CP) develop enlargement of the 
head of the pancreas in consequence of inflammatory alterations, which leads to 
complications such as obstruction of the pancreatic duct, common bile duct stenosis and 
duodenal compression. All of these are indications for surgical treatment. Two types of 
surgical procedures are currently applied in clinical practice: drainage procedures and 
resection operations. Drainage procedures involve a maximal preservation of the pancreatic 
tissue with good early results, which decrease significantly during the follow-up examination. 
Resection operations comprise different types of pancreatic head resection, i.e. conventional 
pancreaticoduodenectomy (Whipple operation), pylorus-preserving pancreaticoduodenectomy 
(PPPD), Beger’s duodenum-preserving pancreatic head  resection (DPPHR) and Frey’s 
longitudinal pancreaticojejeunostomy combined with local pancreatic head excision (LPJ-
LPHE). In accordance with the modern organ-preserving concept, a safe procedure has been 
developed for duodenum-preserving pancreatic head resection in patients with CP. 
Despite the successful, modern surgical intervention in a few cases we found 
recurrence of the disease, and late problems. We tried to get the reason helping us our results 
on the basis of cytokine patomechanism in pancreatitis.  
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2. AIMS OF THE STUDY 
 
As cytokines have a pivotal role in the development of acute and chronic pancreatitis, the aim 
of our study to investigate the role of TNF-α, IL-6 and TGF-β in both diseases. In the first 
part of the study experimental acute pancreatitis models were applied to explore the relevance 
of the cytokines in the pathomechanism of acute pancreatitis. Secondly, the role of TGF-β in 
the chronic pancreatitis was investigated in the clinical practice involving patients with CP. 
Patients with CP were stratified as to patients with mild and severe form. In the case of the 
severe form of CP, a new organ preserving pancreatic head resection was elaborated. 
Description of this new method serves the third part of the thesis; the genetic predisposion of 
these patients is also discussed.  
The present study was designated to address the following aims: 
1.: To determine the changes in serum levels of TNF-α and IL-6 with time in two 
experimental acute pancreatitis models in rats. To find the possibility of correlation between 
the degree of pancreatic tissue injury in interstitial or biliary-type acute pancreatitis and serum 
cytokine level was studied 
2.: To investigate whether changes occur in the serum TGF-β1 levels during pancreas 
regeneration, and whether there is a connection between their levels and the rate of the 
regeneration in rats. 
3.: To develop a safe and effective procedure for organ-preserving pancreatic head resection,  
for definitive control of the complications following the inflammatory alterations of CP. 
4.: To investigate whether TGF-β1 play a role in the development of CP in human, and to find 
a prognostic factor for the successful treatment of CP. 
 
3. MATERIALS AND METHODS 
 
3.1., Experimental pancreatitis 
3.1.1. Acut pancreatitis modells 
3.1.1.1. Animals 
Male Wistar rats weighing 280-330 g were used in all experiments. 
3.1.1.2. CCK-8- induced acute pancreatitis 
The CCK-8-induced acute pancreatitis group (n=5) received 75 ug/kg CCK-8 (sytethysed by 
Botond Penke, Department of Medical Chemistry, Szeged) subcutaneously (s.c.) three times 
at hourly intervals. The control group of animals (n=5) received physiological saline s.c. 
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3.1.1.2. PBDL-induced acute pancreatitis 
The PBDL-induced acute pancreatitis group (n=5) were anesthetized with pentobarbital and 
midline laparotomy was performed. PBDL was achived by ligating the common pancreato-
biliary duct adjacent to the duodenal wall. The control group of animals (n=5) were subjected 
to a midline laparotomy (sham operation) 
3.1.1.3. Experimental protocol 
Animals were killed by abdominal aorta exsanguination 0, 2, 4, 8, 16, 24 or 48h following the 
last CCK-8 injection or PBDL. The pancreas was carefully removed, cleaned of fat and 
weighed. 
 
3.1.1.4. Histological examination  
A fragment of the pancreas was fixed overnight in 10% neutral formaldehyde solution for 
hematoxylin and eosin stuning and for histological study by light microscopy. 
3.1.2. Pancreas regeneration models 
3.1.2.1. Animals 
Male Wistar rats weighing 350-450 g were used in all experiments.  
3.1.2.2. CCK-8-induced regeneration 
In each group the rats (n=5) were anesthetized with ether and midline laparotomy was 
performed. The distal part (75%) of the pancreas was resecated with preserving the spleen. 
CCK-8 was administered subcutaneously in a 300 ng/kg dose 3 times per day to the 
investigated group, while the control animals received the same amount of saline. 
3.1.2.3. Experimental protocol 
Animals were killed by abdominal aorta exsanguination 3, 7, 14, and 28 days after the first 
injection. The residual pancreas was carefully removed, cleaned of fat and weighed. The 
changes in the pancreas weight were calculated in each case to the formerly resecated weights 
respectively, by mathematical methods. 
3.1.3 Assays 
3.1.3.1. Amylase activity 
Serum amylase activity was measured by the Phadebas test method.  
3.1.3.2. TNF and IL-6 assay 
TNF and IL-6 bioassay was performed applying WEHI 164 targets. 
3.1.3.3. Western blot analysis for TGF-β 
TGF-β was detected by an ECL-Western blot technique with the application of anti-TGF-β1 
antibody.  
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3.1.3.4. DNA and protein content 
DNA contents of the pancreas were determined by the procedure of Giles&Meyers, protein 
content by the GOA method; assayed with colorimetric method. 
3.1.3.5. TGF-β assay 
For TGF-β ELISA determination venous blood was collected from the rats into EDTA-
containing tubes for collecting plasma. Blood was collected 3, 7, 14, and 28 days after the 
first CCK-8 injection. Centrifugation was carried out at 2000g for 10 min at 4oC. All samples 
were stored at -20 oC. Plasma concentration of TGF-β1 was determined by enzyme-linked 
immunosorbent assay kit (R&D System Inc., Minneapolis, USA) according to the instructions 
of the manufacturer. 
3.1.4. Statistical analysis 
Results were expressed as mean ± SEM. Experiments were evaluated statistically with 
Student’s t-test for paired or unpaired values, as appropriate. P values less than 0.05 were 
accepted as significant. 
3.2., Human chronic pancreatitis 
3.2.1.: The role of TGF-β1 in patients with CP 
3.2.1.1. Patients 
Our study involved 83 patients (24 females and 59 males; mean age 52.7 years, range 22-70) 
who underwent medical or surgical treatment for chronic pancreatitis at the Department of 
Internal Medicine and/or Department of Surgery of the University of Szeged between 2003 
and 2006. The diagnosis of chronic pancreatitis was based on the typical history (daily alcohol 
intake), abdominal complaints (pain, bloating, steatorrhoea, etc.) and characteristic 
morphologic and/or functional alterations of the pancreas. The morphologic changes due to 
chronic inflammation of the pancreas (pancreatic calcification on ultrasonography /US/ and/or 
computed tomography /CT/, mild to moderate or marked ductal lesions during endoscopic 
retrograde cholangio-pancreatography- /ERCP/ examination) were assessed in each case. 
Pancreatic calcifications were found in 31 (37.5 %) patients on US or CT.  
3.2.1.2. Surgical intervention 
The indication for operation was intractable pain,  loss of  body weight, and obstruction of the 
ductal system (pancreatic duct, common bile duct or  the duodenum) caused by an 
inflammatory  enlargement of  the pancreatic head. Duodenum preserving pancreatic head 
resection was performed in 8 cases, organ preserving pancreatic head resection in 15 cases, 
pylorus preserving pancreatic head resection in 4 cases, and Wirsungo-jejunostomy in 13 
cases. Rehospitalization and reoperation was necessary in 8 cases.The control group consisted 
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of 75 age- and gender-matched healthy blood donors, who had no gastrointestinal or liver 
diseases, were selected locally from consecutive blood donors in Szeged, Hungary.  
3.2.1.3. DNA extraction 
For the examination of TGF-ß1 polymorphisms, genomic DNA purified from peripheral 
blood was used.  
3.2.1.4. Determination of TGF-ß1 +869 T→C polymorphism 
The defined single-nucleotide polymorphism T29-C in exon 1 of the human TGF-ß1 gene was 
determined with an amplification refractory mutation system –ARMS- with a generic primer 
(sense), (5’-TCCGTGGGATACTGAGACACC-3’); and with two allele-specific antisense 
primers, differing from each other in only one base at the 3’-end- primer C: 5’-
GCAGCGGTAGCAGCAGCG-3’ and primer T: 5’-AGCAGCGGTAGCAGCAGCA-3’  
3.2.1.5. TGF-β1 ELISA 
Venous blood was collected from healthy blood donors and patients with chronic pancreatitis 
into EDTA-containing tubes for collecting plasma.  
3.2.1.6. Statistical analysis 
Statistical analyses for comparison of allele and genotype frequencies between groups were 
performed by using the χ2 test and Fisher's exact test if one cell had n < 5.  
3.2.2.: New organ preserving pancreatic head resection in patients with CP 
3.2.2.1. Patients 
Since February 1999, a new surgical procedure has been performed in 135 patients (103 men 
and 32 women; mean age: 49.5 yrs [range 28-63]) after the development of an inflammatory 
tumor of the pancreatic head (median diameter 68 mm [range 46 to 129 mm], as assessed by 
helical CT scan). The etiology was connected with chronic alcohol ingestion in 86% (117 
patients), the CP was associated with biliary stone disease in 14 patients (10%), and it was 
unknown in 4 patients. The diagnosis was confirmed by ERCP, sonography and the CT scan.  
3.2.2.2. Operative procedure 
The operative procedure started with the Kocher maneuver, partial dissection of the 
gastrocolic ligament for mobilization, and exploration of the head of the pancreas, without 
division and cutting of the pancreas over the portal vein. An intraoperative frozen section was 
performed for all patients; none of them revealed signs of malignancy. The following step of 
the operative procedure was ligation of the pancreaticoduodenal artery and the veins directed 
to the duodenum and to the superior mesenteric vein. The enlarged pancreatic head was 
excised in almost its entirety, leaving behind a bridge of pancreatic tissue about 10 mm wide, 
while a rim of pancreas (5 to 10 mm) remained beside the duodenum and on the upper margin 
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of the pancreatic head. This wide excision gives a possibility for drainage of the pancreatic 
juice from the distal pancreas and for opening of the prepapillary obstructed common bile 
duct in the icteric patients and in patients with a stenotic common bile duct. The prestenotic 
dilatated common bile duct was opened with an incision about 8-10 mm long, and the opened 
duct wall was sutured to the surrounding pancreatic tissue with interrupted Vicryl® 3/0 
sutures. After careful hemostasis of the operative region, the reconstruction, with drainage of 
the secretion from the remaining pancreas into the intestinal tract, took place through a jejunal 
Roux-en-Y loop, with application of one-layer interrupted Vicryl® 2/0 sutures. There was no 
indication or necessity for blood transfusion during the operation. The mean operating time 
was 165 min (range 120 to 210 min).  
3.2.2.3. Quality of life 
The QoL and pain score before and after surgeries were assessed and pain intensity was 
estimated. 
3.2.2.4. Statistical analysis  
Statistical significance was estimated by using Student’s t test or the Wilcoxon rank test, as 
appropriate. The level of significance was set at P<0.05. 
 
4. RESULTS 
 
4.1. Experimental acute pancreatitis 
4.1.1: CCK-8-induced pancreatitis 
The ratio pw/bw was significantly increased after the induction of acute pancreatitis and 
reached its maximum level 4 h after the last CCK-8 injection (8.19±1.13 vs. 4.72±0.64 mg/g). 
After 4 h, pw/bw decreased continuously, and it had normalized by 24 h. The serum amylase 
activity rose steadily up to 4 h after the last CCK-8 injection (69.4±12.8x103 
vs.3.12±0.28x103 U/ml). It had reached the control level at 16 h.  
In the CCK-8-induced pancreatitis, the serum IL-6 level had begun to increase at 2 h, but the 
peak level (123.3±5.7 pg/ml) was reached at 4 h. Thereafter it decreased, but it was still 
higher than the control (37.5±15 pg/ml). Detectable TNF was found in CCK-8-induced 
pancreatitis only at 2 h (25.5±5 U/ml).  
Macroscopic study of the pancreata in the CCK-8-treated gropup revealed interstitial 
edema. Microscopic examination demonstrated a moderate diffuse parenchymal degeneration, 
including vacuolation and focal necrosis (dark cells) within the acinar cells. These 
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morphological changes were most evident at 8h and gradually decreased thereafter. The 
interstitium remained virtually unchanged. 
4.1.2. PBDL-induced acute pancreatitis 
In PBDL-induced pancreatitis, the increase in pw/bw was fairly contiuous and it reached its 
maximum leve lat 48 h (8.8±1.4 vs. 5.3±0.8 mg/g). The serum amylase activity peaked 2 h 
after PBDL (43.2±13x103 U/ml), and then decreased continuously. The maximum elevation 
in serum IL-6 level int he PBDL model was observed at 16 h (3800±447 pg/ml). The 
laparotomy itself (sham operation) also resulted in a moderate elevation of the serum IL-6.  
On visual inspection, the pancreata were observed to be enlarged and edematous, with 
occasional hemorrhages. Histologically, increasing edema and infiltration by neutrophilic 
leukocytes and mononuclear phogocytes were seen int he interstitium of the pancreas 2 h after 
ligation. The acinar lumen was dilated and filled with secretion, and the acinar cells were 
partly degranulated. In contrast, the ducts and blood vessels remained unaltered. These 
changes progressed during the experiment. By 8 and 16 h after the ligation, cytoplasmic 
vascuolation of the acinar cells was seen and the acinar cells apeeared to be necrotic. By 24 
and 48 h, areas of intraparenchymal hemorrhage were observed. 
4.1.3. CCK-8 induced pancreas regeneration 
In the pancreas regeneration model the wet weights of the residual pancreas increased in both 
groups up to day 3. Subsequently, the weights decreased in the controls, but increased 
continuously in the CCK-8-treated group. There was a significant difference on day 14, and 
on day 28 the pancreas weight was almost doubled in the CCK-8-group, whereas in the 
controls it has decreased to normal level.  
The protein content reached its highest level on day 28 in the CCK-8-treated group 
(32.435±7.88 mg/pancreas). A significantly higher level of IL-6 was measured on days 7 vs. 
the control (250±70 v. 50±30 pg/ml). It later decreased, but remained above the control level.  
 The DNA content of the pancreas was continuously higher in the treated than in the control 
group. It reached the maximum level on day 28, with significant difference (1850±350 vs. 
780±240 γ/pancreas).  
Significantly different TGF-β1 levels were measured on days 7 and 14 (290±40 vs. 
155±60 and 295±8 vs. 155±55 ng/ml, respectively). There was no difference between the 
TGF-B1 levels in the two groups on day 28.  
Western blotting was applied for the immunodetection of TGF-β in protein lysates of 
pancreas samples, following CCK induction. TGF-β expression in the rat pancreas increased 
from.3 days following CCK treatment up to the 7th day, thereafter the TGF-β level returned 
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to the basal level.,These data underline the role of TGF-β in the regeneration in experimental 
pancreatitis. 
 No significant changes were observed in the amylase levels; they remained at a 
normal level (5.3±0.5 U/ml). This indicates that he increase in the pancreas weight was not 
caused by pancreatitis. 
 
4.2.: Human chronic pancreatitis 
4.2.1. Experimental results 
4.2.1.1. TGF-ß1 +869 T→C polymorphism in patients with CP 
There was a significant difference in genotypic distribution between the chronic 
pancreatic patients overall and the healthy controls (p = 0.009, χ2 = 9.409). The frequency of 
TT homozygote’s (high TGF-β1-producing phenotype) were significantly higher in the 
patient group overall (50%) than in the controls (28%) (p=0.005; OR =2.634; 95% CI = 
1.358-5.111). There was an even  higher frequency of the TT genotype among patients with 
surgical intervention as compared with the controls , 62 % vs. 28 %, p = 0.0007, OR = 4.018, 
95 % CI = 1.796 - 8.987  There was also a significant difference between the operated 
patients, and those treated medically (p = 0.0486, OR=2.549,   95%CI=1.052-6.178). Though 
the frequency of the TT genotype was still higher among the patients in the medically treated 
(non - operated) group (39.5%) than in the controls, the difference was not statistically 
significant. No further significant differences were observed as regards the SNP-s when the 
patients were stratified according to the presence or absence of calcification. The frequency of 
the T/C genotype was significantly higher in both groups of patients than in the controls (58 
%, and 58% vs. 40%) 
4.2.1.2. TGF-β1 plasma levels 
Plasma levels of TGF-β1 were higher in the patients overall than in controls (3.98 ±1.26 
ng/ml vs. 2.1 ± 0.85 ng/ml), and higher in the patients with TT genotype than in those with 
the CT and the CC genotypes (5.2 ± 1.7 ng/ml vs. 3.8 ± 1.1 ng/ml and vs. 1.5 ± 0.5ng/ml 
respectively; p< 0.001 ANOVA). A similar tendency was observed in the control group; the 
subjects with TT genotype exerted the highest plasma TGF-β1 levels (2.8 ± 0.9 ng/ml). 
However, the plasma TGF-β1 concentrations differed significantly between the patients and 
the controls, both in the TT homozygote groups and in the TC heterozygote groups. ( p < 
0.001 statistically significant are according the Bonferroni post test.) No significant difference 
was observed between the”low - level” TGF-β1 concentrations when the patients and controls 
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were CC homozygote. Those patients who had TT genotype with high serum levels of TGF-
β1 were rehospitalized or underwent further operations.  
4.2.2. Surgical results 
In 135 patients, the OPPHR procedure was performed after the development of an 
inflammatory tumour of the pancreatic head. The mean follow-up period was 4.1 years (range 
0.5 to 7.0). Five patients were lost to follow-up (3.7%). 116 patients became complaint-free 
(89%), 14 patients had moderate symptoms and the body weight increased by a mean of 11.3 
kg (range 4-28) (P<0.05). Within 2 years following operations, 5 patients were reoperated: a 
bilio-digestive bypass was performed in consequence of developed bile duct stenosis. In the 
follow-up period, a further 6 patients were admitted to the clinic with an acute episode of 
pancreatitis; all of them were treated conservatively. Readmission was therefore necessary 11 
of the 130 patients (8.4%).  The late mortality was 3.7% (5 patients); the reason was 
cardiovascular failure or an accident, 4 and 1 patient respectively. Both before the operation 
and during the follow-up, the patients were asked to complete the QoL questionnaire. The 
median pain score decreased by 91% (P<0.001) after surgery. No patient suffered a frequent 
pain attack and only 10% of the patients mentioned moderate pain occasionally without any 
pain killer medication. 
 
5. DISCUSSION 
 
5.1., Both the administration of high dose of CCK-8 and ligation of the pancreato-biliary duct 
are suitable methods for the induction of acute pancreatitis, but biochemical and 
morphological examination revealed differences in the severity of changes. The over dosage 
of CCK-8 resulted in a mild oedematous (interstitial) pancreatitis, while PBDL caused a more 
severe necro-hemorrhagic pancreatitis .  
The serum IL-6 level began to rise after the induction of acute pancreatitis and its peak 
preceded the most severe morphological alterations and the maximum amylase concentration 
in both models. The maximum IL-6 level was 30 times higher in the PBDL model than in the 
interstitial pancreatitis model. It is noteworthy that the sham operation itself caused a transient 
elevation of the serum IL-6 level. In human, an increased serum IL-6 concentration has been 
observed after abdominal surgery. This might be the explanation for the increased cytokine 
levels in the sham-operated control animals. 
Only a moderate TNF-α elevation was detected in CCK-8 induced acute pancreatitis, whereas 
its level was increased about 10-fold in the PBDL group. In the PBDL model particularly high 
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IL-6 levels were observed and, concomitantly, significantly higher TNF concentrations could 
be detected. We could demonstrate correlations between the laboratory and morphological 
parameters of pancreatitis and the serum IL-6 levels in both experimental acute pancreatitis 
models. 
5.2., Our study revealed a transient increase in TGF-β1 levels in the CCK-8 treated group. 
The significant changes in the pancreas weight and the protein and DNA contents indicated 
pancreas regeneration and some degree of fibrosis. The TGF-β1 level remained high until day 
14, and then decreased. Additionally the pancreas tropism induced by CCK-8 could be 
detected in increasing level up to the end of the first month. After cerulein-induced 
pancreatitis, TGF-β1 was found to be involved in the regulation of extra cellular matrix 
regeneration. These data show that cytokines can take part and modulate the development of 
the pancreas, and suggest roles for TGF-β1 in regulating the in vivo regeneration of the 
pancreas. 
5.3., In approximately 30% of patients with CP, the disease is primarily located in the head of 
the pancreas, which is known to act as the “pacemaker” to trigger the inflammatory process; 
resection of this inflammatory mass must be regarded as pivotal in the surgical intervention. 
Our data on 135 operated patients demonstrated that OPPHR is a safe operative procedure, as 
confirmed by the low morbidity (2.9%) and the absence of mortality among the patients in the 
postoperative period. An additional important feature is that the median duration of 
hospitalization was only 8.5 days. In the mean follow-up period of 4.1 years (range 0.5 to 
7.0), 116 patients became complaint-free (89%), while 14 had moderate symptoms and the 
body weight increased significantly by a mean of 11.3 kg (range 4-28). Readmission was 
required for 11 of the 130 patients (8.4%) as a consequence of relaparotomy (bilio-digestive 
bypass) or conservatively treated pancreatitis. The late mortality was 3.7%: 5 patients died. 
The preoperative and postoperative endocrine function remained in almost the same stage. 
During the follow-up, the median global QoL improved by 100%. Apart from the cognitive 
functioning, the physical status, working ability, and emotional and social functioning all 
improved significantly (P<0.05).  
5.4., No correlation was found between the genotypes and the histological varieties of chronic 
pancreatitis. The differences in TT genotype frequency proved significant between the 
operated group and the controls, and between the operated and the non operated group. The 
frequency of the TT genotype was relatively high among the medically treated patients, but 
only as a tendency without statistical significance.  
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It is noteworthy, that reoperation was necessary within 3 years in 8 patients; all of them were 
TT homozygote. The highest TGF-β concentrations (5.2 - 7.4 ng/ml) were detected in the 
plasma of these patients.  
Higher concentrations of TGF-β1 were detected in the plasma of the subjects with the TT and 
TC genotypes as compared with those with the CC genotype both among the patients and 
among the controls. The frequency of high producers (TT) was higher among the patients 
with chronic pancreatitis than among the controls, and the TGF-β1 levels differed in the 
patient and control groups. The frequency of the T/C genotype was significantly higher in 
both groups of patients than in the controls (58 %, and 58% vs. 40%). All the successfully 
treated patients carried the genotypes of T/C or C/C with low serum levels of TGF-β1. 
In conclusion, it is very likely that the TGF-β1 polymorphisms contribute to the 
genetic susceptibility to chronic pancreatitis. The TGF-β1 genetic polymorphism with higher 
TGF-β1 production appeared relevant among the patients with chronic pancreatitis, who 
underwent surgery; particularly, when reoperations were necessary. The prognostic value of 
TGF - β1 polymorphism and the associated TGF-β1 levels should be determined in a future 
follow-up study on a larger series of patients. 
From this point of view, if we would like to answer whether Can we treat patients with 
chronic pancreatitis successfully? - The answer is: hopefully YES (if we are prepared to 
consider also the immunological risk factors…) 
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